To elucidate the clinical significance of the protein expression of the signature genes overexpressed in CD5+DLBCL with regard to all DLBCL, not otherwise specified (NOS), 10 genes (SH3BP5,LMO3,SNAP25,SYT5,SV2C,CABP1,FGF1,FGFR2,NEUROD1, and SYN2) were selected and examined immunohistochemically with samples from 28 patients with DLBCL, NOS. This evidence concerns the gene NEUROD1 and diffuse large B-cell lymphoma.